maraviroc

(redirected from Celsentri)
Also found in: Medical.
Related to Celsentri: Selzentry
Translations

maraviroc

n maraviroc m
References in periodicals archive ?
The Committee recommended extensions of indications for Avastin, Celsentri and Opdivo.
Market Access Impact: HIV explores how cost concerns and other barriers affect market share for 8 major HIV treatments: Celsentri, Evotaz, Intelence, Isentress, Stribild, Triumeq, Truvada, and Viread.
ongoing + add on MVC+ RAL(MVC-Maraviroc = Celsentri and RAL-Raltegravir will be delivered as study drugs)Treatment time: 7 years or until endpoint (eradication or virological failure) Study visits CHR: Months -6, -3, BL, M1, 3, 6-monthlly thereafter PHI: Screening/BL, M1, 3, 6-monthlly thereafter.
Pfizer's maraviroc (the imaginatively named Selzentry in the USA; Celsentri elsewhere, licensed in 2007, and awaiting MCC registration in 2009) has been the first out of the starting blocks and has been approved in developed countries for treatment-experienced patients.
Results of two international studies show that Selzentry or Celsentri (maraviroc) helps lower HIV loads to undetectable levels after several other antireiroviral combinations have failed.
Celsentri is thought to be the first new oral HIV treatment in more than a decade and was licensed by regulator the European Agency for the Evaluation of Medicinal Products in September.
The treatment, to be marketed as Celsentri in this country, could be available by the end of the year.